Treatment of Diabetes in Patients With Systolic Heart Failure

NCT02920918 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Heart Failure, Systolic
Diabetes Mellitus, Type 2

Interventions

DRUG: Canagliflozin
DRUG: Sitagliptin

Sponsor

Virginia Commonwealth University

Collaborators

[object Object]